 Maria Gore
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Angiopathies | 6 | 2015 | 259 | 1.450 |
Why?
| | Cardiovascular Diseases | 10 | 2020 | 2111 | 1.270 |
Why?
| | Troponin T | 3 | 2020 | 65 | 1.080 |
Why?
| | Diabetes Mellitus, Type 2 | 14 | 2016 | 2531 | 1.080 |
Why?
| | Myocardial Infarction | 7 | 2015 | 1046 | 1.040 |
Why?
| | Blood Donors | 2 | 2015 | 105 | 0.820 |
Why?
| | Hypoglycemic Agents | 7 | 2015 | 1291 | 0.760 |
Why?
| | Diabetes Mellitus | 3 | 2015 | 1040 | 0.700 |
Why?
| | Veterinary Medicine | 1 | 2019 | 9 | 0.620 |
Why?
| | Prediabetic State | 3 | 2015 | 253 | 0.540 |
Why?
| | Hospice Care | 1 | 2019 | 202 | 0.490 |
Why?
| | Pain | 2 | 2019 | 756 | 0.460 |
Why?
| | Thiazolidinediones | 5 | 2015 | 137 | 0.450 |
Why?
| | Hyperglycemia | 2 | 2015 | 347 | 0.420 |
Why?
| | Risk Reduction Behavior | 1 | 2015 | 220 | 0.410 |
Why?
| | Coronary Disease | 2 | 2015 | 385 | 0.410 |
Why?
| | Heart Failure | 6 | 2015 | 2236 | 0.400 |
Why?
| | Biomarkers | 10 | 2020 | 4149 | 0.390 |
Why?
| | Precision Medicine | 1 | 2016 | 429 | 0.380 |
Why?
| | Arginine | 1 | 2013 | 271 | 0.370 |
Why?
| | Public Health | 1 | 2015 | 588 | 0.330 |
Why?
| | Risk Assessment | 9 | 2020 | 3457 | 0.330 |
Why?
| | Stroke Volume | 3 | 2011 | 612 | 0.310 |
Why?
| | Neoplasms, Connective Tissue | 1 | 2008 | 3 | 0.300 |
Why?
| | Osteomalacia | 1 | 2008 | 4 | 0.300 |
Why?
| | Hypophosphatemia | 1 | 2008 | 17 | 0.290 |
Why?
| | Patient Safety | 1 | 2012 | 314 | 0.290 |
Why?
| | Nose Neoplasms | 1 | 2008 | 25 | 0.290 |
Why?
| | Risk Factors | 13 | 2020 | 10388 | 0.290 |
Why?
| | Cardiovascular System | 1 | 2009 | 137 | 0.270 |
Why?
| | Metformin | 1 | 2011 | 331 | 0.270 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2016 | 3715 | 0.250 |
Why?
| | Troponin | 2 | 2016 | 50 | 0.250 |
Why?
| | Natriuretic Peptide, Brain | 3 | 2020 | 99 | 0.240 |
Why?
| | Insulin Resistance | 1 | 2013 | 1208 | 0.230 |
Why?
| | Sex Distribution | 2 | 2015 | 375 | 0.220 |
Why?
| | Texas | 6 | 2014 | 244 | 0.210 |
Why?
| | Humans | 32 | 2020 | 137585 | 0.210 |
Why?
| | Hospitalization | 2 | 2012 | 2199 | 0.210 |
Why?
| | Middle Aged | 20 | 2020 | 33479 | 0.200 |
Why?
| | Oxygen Consumption | 4 | 2014 | 696 | 0.200 |
Why?
| | Obesity | 2 | 2015 | 2992 | 0.190 |
Why?
| | Rest | 2 | 2013 | 121 | 0.190 |
Why?
| | Aged | 15 | 2020 | 23961 | 0.190 |
Why?
| | Male | 23 | 2020 | 67762 | 0.180 |
Why?
| | Female | 23 | 2020 | 73304 | 0.180 |
Why?
| | Sex Factors | 4 | 2017 | 2071 | 0.170 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 2031 | 0.170 |
Why?
| | Cohort Studies | 4 | 2015 | 5742 | 0.170 |
Why?
| | Peptide Fragments | 2 | 2020 | 706 | 0.170 |
Why?
| | Insulin | 1 | 2011 | 2409 | 0.170 |
Why?
| | C-Reactive Protein | 2 | 2020 | 410 | 0.160 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2020 | 90 | 0.160 |
Why?
| | Education, Veterinary | 1 | 2019 | 3 | 0.160 |
Why?
| | Cross-Sectional Studies | 6 | 2017 | 5472 | 0.150 |
Why?
| | Pets | 1 | 2019 | 26 | 0.150 |
Why?
| | Myocardium | 3 | 2014 | 1002 | 0.140 |
Why?
| | Evidence-Based Medicine | 2 | 2012 | 740 | 0.140 |
Why?
| | Electrocardiography | 1 | 2020 | 629 | 0.130 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 530 | 0.130 |
Why?
| | Glycemic Index | 1 | 2016 | 27 | 0.130 |
Why?
| | Universities | 1 | 2019 | 433 | 0.130 |
Why?
| | Prospective Studies | 6 | 2015 | 7604 | 0.120 |
Why?
| | Cardiac Output | 2 | 2013 | 165 | 0.120 |
Why?
| | Transcutaneous Electric Nerve Stimulation | 2 | 2007 | 23 | 0.120 |
Why?
| | Early Diagnosis | 2 | 2014 | 242 | 0.120 |
Why?
| | Aged, 80 and over | 3 | 2020 | 7635 | 0.120 |
Why?
| | Troponin I | 1 | 2016 | 81 | 0.120 |
Why?
| | Prognosis | 3 | 2013 | 4030 | 0.120 |
Why?
| | Homoarginine | 1 | 2014 | 2 | 0.110 |
Why?
| | Atherosclerosis | 3 | 2014 | 415 | 0.110 |
Why?
| | Time Factors | 4 | 2012 | 6828 | 0.110 |
Why?
| | Age Distribution | 1 | 2015 | 392 | 0.110 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2014 | 36 | 0.110 |
Why?
| | Hypercholesterolemia | 1 | 2015 | 106 | 0.110 |
Why?
| | Reference Values | 2 | 2014 | 816 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2014 | 5131 | 0.110 |
Why?
| | Proportional Hazards Models | 2 | 2014 | 1266 | 0.100 |
Why?
| | Blood Chemical Analysis | 1 | 2014 | 99 | 0.100 |
Why?
| | Biological Assay | 1 | 2014 | 124 | 0.100 |
Why?
| | Cholesterol | 1 | 2015 | 410 | 0.100 |
Why?
| | Triglycerides | 2 | 2014 | 524 | 0.100 |
Why?
| | Physical Fitness | 1 | 2014 | 209 | 0.100 |
Why?
| | United States | 3 | 2015 | 14841 | 0.100 |
Why?
| | Life Style | 1 | 2015 | 490 | 0.100 |
Why?
| | Curriculum | 1 | 2019 | 992 | 0.090 |
Why?
| | Urban Population | 1 | 2015 | 479 | 0.090 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2014 | 323 | 0.090 |
Why?
| | Renal Insufficiency | 1 | 2014 | 162 | 0.090 |
Why?
| | Blood Glucose | 2 | 2014 | 2186 | 0.090 |
Why?
| | Drug Approval | 1 | 2012 | 88 | 0.090 |
Why?
| | Pilot Projects | 2 | 2014 | 1710 | 0.090 |
Why?
| | Survival Analysis | 2 | 2012 | 1325 | 0.090 |
Why?
| | Ventricular Function | 1 | 2011 | 61 | 0.090 |
Why?
| | Rural Population | 1 | 2015 | 563 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1289 | 0.080 |
Why?
| | Edema | 1 | 2011 | 130 | 0.080 |
Why?
| | Diabetic Nephropathies | 1 | 2014 | 294 | 0.080 |
Why?
| | Adult | 9 | 2017 | 37929 | 0.080 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 530 | 0.080 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 201 | 0.080 |
Why?
| | Diabetes Complications | 1 | 2011 | 227 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1946 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2014 | 2828 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1509 | 0.080 |
Why?
| | Colorado | 1 | 2019 | 4565 | 0.070 |
Why?
| | Ilium | 1 | 2008 | 25 | 0.070 |
Why?
| | Coronary Artery Disease | 2 | 2015 | 698 | 0.070 |
Why?
| | Quinolines | 1 | 2009 | 178 | 0.070 |
Why?
| | Hospital Mortality | 1 | 2012 | 911 | 0.070 |
Why?
| | Registries | 2 | 2014 | 2035 | 0.070 |
Why?
| | Blood Pressure | 1 | 2015 | 1786 | 0.070 |
Why?
| | Delayed Diagnosis | 1 | 2008 | 91 | 0.070 |
Why?
| | Survival Rate | 1 | 2012 | 1972 | 0.070 |
Why?
| | United Kingdom | 1 | 2009 | 318 | 0.070 |
Why?
| | Young Adult | 2 | 2015 | 13209 | 0.070 |
Why?
| | Anticholesteremic Agents | 1 | 2009 | 153 | 0.070 |
Why?
| | Logistic Models | 1 | 2012 | 2074 | 0.070 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 1050 | 0.070 |
Why?
| | Comorbidity | 1 | 2012 | 1622 | 0.070 |
Why?
| | Ambulances | 1 | 2007 | 51 | 0.060 |
Why?
| | Mass Screening | 1 | 2015 | 1287 | 0.060 |
Why?
| | Emergency Medical Technicians | 1 | 2007 | 36 | 0.060 |
Why?
| | Age Factors | 1 | 2014 | 3295 | 0.060 |
Why?
| | Hypertension | 1 | 2015 | 1295 | 0.060 |
Why?
| | Hip Fractures | 1 | 2007 | 86 | 0.060 |
Why?
| | Atrial Natriuretic Factor | 1 | 2005 | 57 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1313 | 0.060 |
Why?
| | Adolescent | 2 | 2015 | 21513 | 0.060 |
Why?
| | Transportation of Patients | 1 | 2005 | 55 | 0.060 |
Why?
| | Biopsy | 1 | 2008 | 1129 | 0.060 |
Why?
| | Models, Biological | 1 | 2011 | 1783 | 0.050 |
Why?
| | Low Back Pain | 1 | 2005 | 108 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1477 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2012 | 10811 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3284 | 0.040 |
Why?
| | Exercise Test | 2 | 2014 | 625 | 0.040 |
Why?
| | Ventricular Function, Left | 2 | 2014 | 534 | 0.040 |
Why?
| | Double-Blind Method | 3 | 2011 | 1993 | 0.040 |
Why?
| | Hemodynamics | 2 | 2013 | 1113 | 0.030 |
Why?
| | Animals | 1 | 2019 | 36940 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 3 | 2014 | 3566 | 0.030 |
Why?
| | Prevalence | 2 | 2014 | 2734 | 0.030 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 20 | 0.030 |
Why?
| | Contraindications | 1 | 2014 | 90 | 0.030 |
Why?
| | Carbazoles | 1 | 2014 | 83 | 0.030 |
Why?
| | Propanolamines | 1 | 2014 | 96 | 0.030 |
Why?
| | Urban Health | 1 | 2014 | 92 | 0.030 |
Why?
| | Lymphotoxin beta Receptor | 1 | 2013 | 2 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 198 | 0.020 |
Why?
| | Glycation End Products, Advanced | 1 | 2013 | 82 | 0.020 |
Why?
| | Aorta | 1 | 2014 | 417 | 0.020 |
Why?
| | ROC Curve | 1 | 2013 | 554 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2013 | 275 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 199 | 0.020 |
Why?
| | Plasma Volume | 1 | 2011 | 19 | 0.020 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2014 | 382 | 0.020 |
Why?
| | Hematocrit | 1 | 2011 | 96 | 0.020 |
Why?
| | Molecular Weight | 1 | 2011 | 335 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2014 | 512 | 0.020 |
Why?
| | Ultrasonography | 1 | 2014 | 759 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2011 | 282 | 0.020 |
Why?
| | Serum Albumin | 1 | 2011 | 150 | 0.020 |
Why?
| | Adiposity | 1 | 2014 | 518 | 0.020 |
Why?
| | Adiponectin | 1 | 2011 | 244 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2011 | 433 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 849 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 1024 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2011 | 611 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2804 | 0.020 |
Why?
| | Weight Gain | 1 | 2011 | 519 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2844 | 0.020 |
Why?
| | Decision Making | 1 | 2013 | 900 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 2085 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1316 | 0.010 |
Why?
| | Body Mass Index | 1 | 2011 | 2389 | 0.010 |
Why?
| | Pain Measurement | 1 | 2005 | 521 | 0.010 |
Why?
| | Acute Disease | 1 | 2005 | 1007 | 0.010 |
Why?
| | Heart Rate | 1 | 2005 | 822 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2007 | 552 | 0.010 |
Why?
| | Anxiety | 1 | 2005 | 1035 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2013 | 15657 | 0.010 |
Why?
|
|
Gore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|